• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿科移植受者的抗病毒治疗。

Antiviral Therapeutics in Pediatric Transplant Recipients.

机构信息

Division of Infectious Diseases, Department of Pediatrics, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104-4399, USA.

Division of Infectious Diseases, Department of Pediatrics, Washington University, 425 S. Euclid Avenue, McDonnell Pediatric Research Building, #5105, St Louis, MO 63106, USA.

出版信息

Infect Dis Clin North Am. 2022 Mar;36(1):125-146. doi: 10.1016/j.idc.2021.11.004.

DOI:10.1016/j.idc.2021.11.004
PMID:35168706
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8900721/
Abstract

Recipients of solid organ and hematopoietic stem cell transplantation undergo substantial immune suppression, placing them at risk for opportunistic viral infection. Few randomized controlled trials have been dedicated to the treatment of viral infections in children, and current practices are extrapolated from data generated from adult patients. Here we discuss the prevention and treatment of viral infections using available antiviral drugs, as well as novel agents that may provide benefit to pediatric patients in the future.

摘要

实体器官和造血干细胞移植受者接受大量免疫抑制治疗,使他们面临机会性病毒感染的风险。很少有随机对照试验专门针对儿童病毒感染的治疗,目前的治疗方法是从成人患者的数据中推断出来的。在这里,我们讨论了使用现有抗病毒药物预防和治疗病毒感染的问题,以及未来可能对儿科患者有益的新型药物。

相似文献

1
Antiviral Therapeutics in Pediatric Transplant Recipients.儿科移植受者的抗病毒治疗。
Infect Dis Clin North Am. 2022 Mar;36(1):125-146. doi: 10.1016/j.idc.2021.11.004.
2
Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?儿科移植受者中的腺病毒感染:有效的抗病毒药物即将问世吗?
Curr Opin Organ Transplant. 2018 Aug;23(4):395-399. doi: 10.1097/MOT.0000000000000542.
3
Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.造血干细胞移植受者中的乙型肝炎病毒:拉丁美洲某中心抗病毒治疗对血清学转换、植入和死亡率的影响
Transpl Infect Dis. 2020 Apr;22(2):e13243. doi: 10.1111/tid.13243. Epub 2020 Jan 13.
4
Rhodococcus Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients.实体器官和造血干细胞移植受者中的红球菌感染
Emerg Infect Dis. 2017 Mar;23(3):510-512. doi: 10.3201/eid2303.160633.
5
Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients.评估和恢复实体器官和造血细胞移植受者对 HSV、VZV 和 HHV-6 的适应性免疫。
Clin Microbiol Infect. 2022 Oct;28(10):1345-1350. doi: 10.1016/j.cmi.2022.02.001. Epub 2022 Feb 10.
6
Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues.造血干细胞移植受者中水痘-带状疱疹病毒感染的暴露后预防:未解决的问题。
Infect Control Hosp Epidemiol. 2004 Jul;25(7):603-8. doi: 10.1086/502447.
7
Current and Emerging Antiviral Agents in the Prevention and Treatment of Cytomegalovirus in Pediatric Transplant Recipients.目前和新兴的抗病毒药物在儿科移植受者巨细胞病毒预防和治疗中的应用。
J Pediatric Infect Dis Soc. 2024 Feb 28;13(Supplement_1):S14-S21. doi: 10.1093/jpids/piad059.
8
Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation.实体器官和造血干细胞移植后巨细胞病毒感染的药物和免疫治疗管理。
Expert Rev Clin Pharmacol. 2018 Aug;11(8):773-788. doi: 10.1080/17512433.2018.1501557. Epub 2018 Jul 26.
9
Viral infections in immunocompromised patients: what's new with respiratory viruses?免疫功能低下患者的病毒感染:呼吸道病毒有哪些新情况?
Curr Opin Infect Dis. 2002 Aug;15(4):355-67. doi: 10.1097/00001432-200208000-00002.
10
[Update on the management of cytomegalovirus infection in transplant recipients].[移植受者巨细胞病毒感染管理的最新进展]
Rev Med Suisse. 2023 Apr 12;19(822):726-730. doi: 10.53738/REVMED.2023.19.822.726.

引用本文的文献

1
Final outcomes from a phase 2 trial of posoleucel in allogeneic hematopoietic cell transplant recipients.异体造血细胞移植受者中 posoleucel 的 2 期试验的最终结果。
Blood Adv. 2024 Sep 10;8(17):4740-4750. doi: 10.1182/bloodadvances.2023011562.
2
A quick algorithmic review on management of viral infectious diseases in pediatric solid organ transplant recipients.小儿实体器官移植受者病毒性传染病管理的快速算法综述
Front Pediatr. 2023 Sep 4;11:1252495. doi: 10.3389/fped.2023.1252495. eCollection 2023.
3
How I treat cytopenias after CAR T-cell therapy.

本文引用的文献

1
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.玛巴洛沙韦用于移植后伴有或不伴有耐药性的难治性巨细胞病毒感染:一项3期随机临床试验的结果
Clin Infect Dis. 2022 Sep 10;75(4):690-701. doi: 10.1093/cid/ciab988.
2
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial.在有流感并发症风险的青少年和成年门诊患者中早期使用巴洛沙韦治疗(CAPSTONE-2):一项随机、安慰剂对照、3 期临床试验。
Lancet Infect Dis. 2020 Oct;20(10):1204-1214. doi: 10.1016/S1473-3099(20)30004-9. Epub 2020 Jun 8.
3
我如何治疗 CAR T 细胞治疗后的血细胞减少症。
Blood. 2023 May 18;141(20):2460-2469. doi: 10.1182/blood.2022017415.
Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation.
在季节性大流行的 H1N1 流感期间,预防性使用奥司他韦可能会降低接受单倍体相合移植的儿童中 H1N1 流感和相关的肺曲霉病的发生率。
Transpl Infect Dis. 2020 Oct;22(5):e13309. doi: 10.1111/tid.13309. Epub 2020 Jun 8.
4
Cytomegalovirus Infection in Solid Organ and Hematopoietic Cell Transplantation: State of the Evidence.实体器官和造血细胞移植中的巨细胞病毒感染:证据状况
J Infect Dis. 2020 Mar 5;221(Suppl 1):S23-S31. doi: 10.1093/infdis/jiz454.
5
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.一项评估 Presatovir 治疗造血干细胞移植受者呼吸道合胞病毒上呼吸道感染的 2 期、随机、双盲、安慰剂对照研究。
Clin Infect Dis. 2020 Dec 31;71(11):2777-2786. doi: 10.1093/cid/ciz1166.
6
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant.接受异基因造血干细胞移植儿童中灭活流感疫苗的免疫原性。
Bone Marrow Transplant. 2020 Apr;55(4):773-779. doi: 10.1038/s41409-019-0728-5. Epub 2019 Oct 28.
7
Anti-herpesvirus prophylaxis, pre-emptive treatment or no treatment in adults undergoing allogeneic transplant for haematological disease: systematic review and meta-analysis.血液疾病患者行异基因移植时的抗病毒预防、先发治疗与无治疗:系统评价与荟萃分析。
Clin Microbiol Infect. 2020 Feb;26(2):189-198. doi: 10.1016/j.cmi.2019.09.003. Epub 2019 Sep 16.
8
Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.水痘带状疱疹病毒在实体器官移植中的研究:美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13622. doi: 10.1111/ctr.13622. Epub 2019 Jul 22.
9
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7).血液病患者和造血干细胞移植后巨细胞病毒感染管理指南,源自 2017 年白血病感染的欧洲会议(ECIL 7)。
Lancet Infect Dis. 2019 Aug;19(8):e260-e272. doi: 10.1016/S1473-3099(19)30107-0. Epub 2019 May 29.
10
Herpes simplex virus infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植中的单纯疱疹病毒感染:美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13526. doi: 10.1111/ctr.13526. Epub 2019 Apr 11.